A Phase I vaccine trial using dendritic cells pulsed with autologous oxidized lysate for recurrent ovarian cancer
/in Dendritic Cells, International Publications, Ovarian Cancer /von 2013-06-18 / J Transl Med 2013 Jun;11:149Biochemical and immunologic markers in patients with metastatic melanoma treated with chemotherapy and dendritic cell vaccine.
/in Dendritic Cells, International Publications, Malignant Melanoma /von 2013-06-04 / J Clin Oncol 31, 2013 (suppl; abstr e20042)Immune response, clinical outcome and safety of dendritic cell vaccine in combination with cytokine-induced killer cell therapy in cancer patients
/in Dendritic Cells, International Publications /von 2013-06-04 / Oncol Lett 2013 Aug;6(2):537-541Effect of vaccination with autologous tumor-loaded dendritic cells on intratumoral regulatory T cells in metastatic melanoma patients.
/in Dendritic Cells, International Publications, Malignant Melanoma /von 2013-06-03 / J Clin Oncol 31, 2013 (suppl; abstr 3040)Survival in metastatic Ewing sarcoma (EWS) and rhabdomyosarcoma (RMS) following consolidation immunotherapy with autologous lymphocyte infusion, dendritic cell vaccines ± CYT107 (rhIL-7).
/in Dendritic Cells, Hypernephroma, International Publications, Soft Tissue Sarcoma /von 2013-06-03 / J Clin Oncol 31, 2013 (suppl; abstr 10013)Phase II study of dendritic cell vaccination combined with recombinant adenovirus-p53 in treatment for patients with advanced pancreatic carcinoma.
/in Dendritic Cells, Pancreatic Cancer /von 2013-06-03 / J Clin Oncol 31, 2013 (suppl; abstr 3049)Immunogenicity of dendritic cells pulsed with MAGE3, Survivin and B-cell maturation antigen mRNA for vaccination of multiple myeloma patients
/in Dendritic Cells, International Publications, Multiple Myeloma /von 2013-06-02 / Cancer Immunol. Immunother. 2013 Aug;62(8):1381-92Allogeneic dendritic cell (DC) vaccination as an “off the shelf” treatment to prevent or delay relapse in elderly acute myeloid leukemia patients: Results of phase I study.
/in Acute Leukemia, Dendritic Cells, International Publications /von 2013-06-01 / J Clin Oncol 31, 2013 (suppl; abstr 3029)Impact of dendritic cells combining with cytokine-induced killer cells synergized chemotherapy in patients of advanced non-small cell lung cancer.
/in Dendritic Cells, NSCLC /von 2013-05-31 / J Clin Oncol 31, 2013 (suppl; abstr e19018)IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de